Close
Show

Press Releases

Press Releases is unique and effective promotional tool offered from Worldpharmatoday.com aimed at bringing our client’s business message into limelight and more importantly make it reach their target audience. This feature can be utilized to launch new product, promoting existing Pharma product, publish business agreements, annual reports, financial results, corporate performances, important announcements or any important information that has to be conveyed to the target audience.

AstraZeneca launches integrated genomics approach to transform drug discovery and development


AstraZeneca and its global biologics research and development arm, MedImmune, today announced an integrated genomics...

CPhI Istanbul hosts government and industry to strengthen Turkey as MENA pharma hub


CPhI Istanbul 2016, organised by UBM EMEA, returns for the third consecutive year to Turkey,...

Novo Nordisk plans to invest more than 100 million euros in production plants in...


Novo Nordisk announced that it plans to invest more than 100 million euros in production...

Baxter Receives Marketing Authorization of Nutrition for Preterm Newborns in UK and Denmark


Baxter International Inc announced it has received Marketing Authorization from the Competent Authorities in the...

Eisai presents Non-Clinical Research Findings in 107th Annual Meeting of American Association for Cancer...


Enhanced Mechanism Of Angiogenesis Inhibition And Anti-Tumor Activity In Renal Cell Carcinoma Investigated ...

Merck Receives Breakthrough Therapy Designation from U.S. FDA for KEYTRUDA® in Classical Hodgkin...


Merck known as MSD outside the United States and Canada, today announced that the U.S....

Bayer to present latest preclinical data on oncology compounds in 107th Annual Meeting of...


Bayer will present latest preclinical data on oncology compounds, which are currently in preclinical or...

Kanuma receives marketing approval in Japan for Treatment of Patients with Lysosomal Acid Lipase...


Alexion Pharmaceuticals, Inc announced that Japan’s Ministry of Health, Labour and Welfare has approved Kanuma...

Phase 3 Study Findings Demonstrate Treatment With Baricitinib Results In Significant Improvements For Patients...


Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced that detailed results...

Proteostasis Therapeutics, Inc. Presents New Data Demonstrating Potential for Genotype-Agnostic and Combination Therapies for...


Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases...